0001104659-23-086060.txt : 20230801
0001104659-23-086060.hdr.sgml : 20230801
20230801080007
ACCESSION NUMBER: 0001104659-23-086060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230731
FILED AS OF DATE: 20230801
DATE AS OF CHANGE: 20230801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mosseri Marlio Charles
CENTRAL INDEX KEY: 0001806384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 231129700
MAIL ADDRESS:
STREET 1: 27 RIPPLEVALE GROVE
CITY: LONDON
STATE: X0
ZIP: N1 1HS
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2322480-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-07-31
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001806384
Mosseri Marlio Charles
27 RIPPLEVALE GROVE
LONDON
N1
1HS
LIBYAN ARAB JAMAHIRIYA
0
0
1
0
0
Common Stock
2023-07-31
4
P
0
860
13.88
A
2595000
D
/s/ Charles Mosseri-Marlio
2023-08-01